Effect of Prednisolone Treatment on Uterine Natural Killer Cells
ConditionRecurrent Miscarriage
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorChinese University of Hong Kong
About this trial
This study aims to investigate the role of uNK cells and the association with prednisolone.
Eligibility criteria
Qualifiers
Women with a history of 3 or more consecutive miscarriages
Women younger than 40 years old
Disqualifiers
Allergy to prednisolone
Women who have any uterine anomaly
Antiphospholipid syndrome
Hydrosalpinx
Trial design
Treatments tested in this trial
- Prednisolone
Treatment groups
84 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov